UN, S., A, B., T, C., SCL, S., OM, N., M, L., . . . M, I. (2020). Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy. Therapeutic advances in gastroenterology, 13, 1756284820981216. https://doi.org/10.1177/1756284820981216
Chicago Style (17th ed.) CitationUN, Shivaji, Bazarova A, Critchlow T, Smith SCL, Nardone OM, Love M, Davis J, Ghosh S, and Iacucci M. "Clinical Outcomes, Predictors of Prognosis and Health Economics Consequences in IBD Patients After Discontinuation of the First Biological Therapy." Therapeutic Advances in Gastroenterology 13 (2020): 1756284820981216. https://doi.org/10.1177/1756284820981216.
MLA (9th ed.) CitationUN, Shivaji, et al. "Clinical Outcomes, Predictors of Prognosis and Health Economics Consequences in IBD Patients After Discontinuation of the First Biological Therapy." Therapeutic Advances in Gastroenterology, vol. 13, 2020, p. 1756284820981216, https://doi.org/10.1177/1756284820981216.